- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
59 Lymphocytic Leukemia Trials Near You
Power is an online platform that helps thousands of Lymphocytic Leukemia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerIbrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
154 Participants Needed
LP-118 for Leukemia
Trial Details
Key Eligibility Criteria
100 Participants Needed
Pirtobrutinib for Lymphoma
Trial Details
Key Eligibility Criteria
279 Participants Needed
Lenalidomide + Blinatumomab for Lymphoma
Trial Details
Key Eligibility Criteria
44 Participants Needed
Acalabrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
306 Participants Needed
Zilovertamab Vedotin for Lymphoma
Trial Details
Key Eligibility Criteria
223 Participants Needed
Oral LOXO-305 for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
860 Participants Needed
Acalabrutinib + Pembrolizumab for Blood Cancers
Trial Details
Key Eligibility Criteria
161 Participants Needed
TL-895 + Navtemadlin for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
130 Participants Needed
LP-168 for Lymphoma
Trial Details
Key Eligibility Criteria
60 Participants Needed
Long-term Ibrutinib for Lymphoma
Trial Details
Key Eligibility Criteria
700 Participants Needed
Trial Details
Key Eligibility Criteria
313 Participants Needed
Nemtabrutinib for Blood Cancers
Trial Details
Key Eligibility Criteria
190 Participants Needed
Trial Details
Key Eligibility Criteria
6 Participants Needed
Vaccine Therapy for Blood Cancers
Trial Details
Key Eligibility Criteria
61 Participants Needed
CAR T-cell Therapy for Lymphoma and Leukemia
Trial Details
Key Eligibility Criteria
54 Participants Needed
Gene Therapy for Acute Lymphoblastic Leukemia
Trial Details
Key Eligibility Criteria
32 Participants Needed
DR-01 for Leukemia and Lymphoma
Trial Details
Key Eligibility Criteria
69 Participants Needed
Geriatric Care Optimization for Blood Cancers
Trial Details
Key Eligibility Criteria
30 Participants Needed
SGR-1505 for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
52 Participants Needed
Why Other Patients Applied
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
Acalabrutinib for Leukemia
Trial Details
Key Eligibility Criteria
61 Participants Needed
Zanubrutinib + CAR T-Cell Therapy for Richter's Syndrome
Trial Details
Key Eligibility Criteria
24 Participants Needed
KT-333 for Lymphoma and Cancer
Trial Details
Key Eligibility Criteria
120 Participants Needed
AC676 for B-Cell Malignancies
Trial Details
Key Eligibility Criteria
60 Participants Needed
CAR T-Cell Therapy for Leukemia and Lymphoma
Trial Details
Key Eligibility Criteria
12 Participants Needed
JCAR017 for Chronic Leukemia or Lymphoma
Trial Details
Key Eligibility Criteria
320 Participants Needed
Ruxolitinib for Large Granular Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
28 Participants Needed
Oral Azacitidine for Leukemia
Trial Details
Key Eligibility Criteria
27 Participants Needed
XEMBIFY® for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
386 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Lymphocytic Leukemia clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Lymphocytic Leukemia clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Lymphocytic Leukemia trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Lymphocytic Leukemia is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Lymphocytic Leukemia medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Lymphocytic Leukemia clinical trials?
Most recently, we added Pirtobrutinib for Chronic Lymphocytic Leukemia, CAR T-Cell Therapy for Leukemia and Lymphoma and Gene Therapy for Acute Lymphoblastic Leukemia to the Power online platform.